These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 21882947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E.
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
    Prével C, Kurzawa L, Van TN, Morris MC.
    Eur J Med Chem; 2014 Dec 17; 88():74-88. PubMed ID: 25314935
    [Abstract] [Full Text] [Related]

  • 6. Coming full circle: cyclin-dependent kinases as anti-cancer drug targets.
    Fisher RP.
    Subcell Biochem; 2010 Dec 17; 50():1-15. PubMed ID: 20012574
    [Abstract] [Full Text] [Related]

  • 7. Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
    Kalra S, Joshi G, Munshi A, Kumar R.
    Eur J Med Chem; 2017 Dec 15; 142():424-458. PubMed ID: 28911822
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of cyclin-dependent kinase inhibitor, CR229, using structurebased drug screening.
    Kim MK, Min J, Choi BY, Lim H, Cho YH, Lee CH.
    J Microbiol Biotechnol; 2007 Oct 15; 17(10):1712-6. PubMed ID: 18156791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP.
    J Mol Biol; 1999 Apr 16; 287(5):821-8. PubMed ID: 10222191
    [Abstract] [Full Text] [Related]

  • 18. Understanding the Structural Basis for Inhibition of Cyclin-Dependent Kinases. New Pieces in the Molecular Puzzle.
    Levin NMB, Pintro VO, de Avila MB, de Mattos BB, De Azevedo WF.
    Curr Drug Targets; 2017 Apr 16; 18(9):1104-1111. PubMed ID: 27848884
    [Abstract] [Full Text] [Related]

  • 19. Control of the G1/S transition.
    Reed SI.
    Cancer Surv; 1997 Apr 16; 29():7-23. PubMed ID: 9338094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.